نتایج جستجو برای: chronic gvhd

تعداد نتایج: 500551  

Journal: :Brazilian journal of otorhinolaryngology 2006
Erica Ortiz Eulalia Sakano Carmino Antonio De Souza Afonso Vigorito Katia A B Eid

INTRODUCTION Bone marrow transplantation (BMT) is a treatment option for hematological diseases and immunodeficiency. It is frequently used today. BMT predisposes patients to upper airway infections and its complications, such as rhinosinusitis (RS). Chemotherapy, radiotherapy, viral infections, antibiotic therapy, graft versus host disease (GVHD) are rhinosinusitis predisposing conditions. A...

Journal: :Haematologica 2006
Hugues de Lavallade Mohamad Mohty Catherine Faucher Sabine Fürst Jean El-Cheikh Didier Blaise

This study investigated the use of low dose methotrexate (MTX) (5 mg/m2/infusion) for the treatment of graft-versus-host disease (GVHD), after failure of corticosteroids. Twelve patients had refractory acute GVHD, while eight received MTX for severe chronic GVHD and/or the side effects of corticosteroids. Thirteen patients responded to MTX with six complete remissions and little toxicity, sugge...

Journal: :Journal of immunology 2003
Arun R Rao Marlon P Quinones Edgar Garavito Yogeshwar Kalkonde Fabio Jimenez Caroline Gibbons Jennifer Perez Peter Melby William Kuziel Robert L Reddick Sunil K Ahuja Seema S Ahuja

The complete repertoire of cellular and molecular determinants that influence graft-vs-host disease (GVHD) is not known. Using a well-established murine model of GVHD (B6-->bm12 mice), we sought to elucidate the role of the donor non-T cell compartment and molecular determinants therein in the pathogenesis of GVHD. In this model the acute GVHD-inducing effects of purified B6 wild-type (wt) CD4(...

Journal: :The Journal of clinical investigation 2000
W J Murphy

Graft-versus-host disease (GVHD) commonly occurs when immunocompetent donor cells attack a genetically disparate host. GVHD occurs primarily after allogeneic bone marrow transplantation (BMT) and remains a significant cause of morbidity, thus limiting the efficacy of this treatment. GVHD can exist as two distinct clinical entities: acute (affecting multiple solid organs) and chronic (presenting...

Journal: :Blood 2011
James M Coghill Stefanie Sarantopoulos Timothy P Moran William J Murphy Bruce R Blazar Jonathan S Serody

GVHD is a syndrome that results from minor and major histocompatibility complex incompatibilities between the donor and recipient. More than 50 years after its initial description, the pathophysiology of GVHD remains poorly understood. Nonetheless, donor T cells have been shown to be critical to the pathophysiology of acute and chronic GVHD, yet precisely how they function remains unclear. The ...

Journal: :Hematology. American Society of Hematology. Education Program 2008
Stephanie J Lee Mary E D Flowers

Chronic graft-versus-host disease (GVHD) is an immune-mediated disorder that occurs frequently after allogeneic hematopoietic cell transplantation (HCT). Most cases are diagnosed within the first year at a median of 4 to 6 months after HCT, but 5-10% of cases are initially diagnosed beyond the first post-transplant year. Chronic GVHD most often involves the skin and mouth, but almost any other ...

Journal: :Blood 2009
David A Jacobsohn Andrew L Gilman Alfred Rademaker Brittan Browning Michael Grimley Leslie Lehmann Eneida R Nemecek Kimberly Thormann Kirk R Schultz Georgia B Vogelsang

There is no standard therapy for steroid-refractory chronic graft-versus-host disease (GVHD). This problem is particularly daunting in children with chronic GVHD, whereby the effects of the disease and its treatment may impair normal growth and development. Children are also particularly vulnerable to failure and/or toxicity of therapy; for example, joint contractures or joint damage may result...

Journal: :Blood 2006
Daniel R Couriel Chitra Hosing Rima Saliba Elizabeth J Shpall Paolo Anderlini Beverly Rhodes Veronica Smith Issa Khouri Sergio Giralt Marcos de Lima Yvonne Hsu Shubhra Ghosh Joyce Neumann Borje Andersson Muzzafar Qazilbash Sharon Hymes Stella Kim Richard Champlin Michele Donato

Chronic graft-versus-host disease (GVHD) is a major limitation of successful allogeneic hematopoietic stem cell transplantation (HSCT). Extracorporeal photochemotherapy (ECP) has been tested extensively in small cohorts of patients with chronic GVHD. In this study, we retrospectively evaluated 71 patients with severe chronic GVHD treated with ECP. Response rate was 61% (n = 43), and 14 patients...

Journal: :Blood 2013
Yoshihiro Inamoto Barry E Storer Effie W Petersdorf J Lee Nelson Stephanie J Lee Paul A Carpenter Brenda M Sandmaier John A Hansen Paul J Martin Mary E D Flowers

Sclerotic chronic graft-versus-host disease (GVHD) can result in disability after allogeneic hematopoietic cell transplantation. We assessed the incidence and risk factors of sclerosis and its association with transplant outcomes among 977 consecutive patients treated with systemic immunosuppression for chronic GVHD. Sclerosis was defined when cutaneous sclerosis, fasciitis, or joint contractur...

1999

Thalidomide has one of the most notorious drug histories because of its teratogenicity. Its widespread use in the 1960s led to a worldwide epidemic of phocomelia in inborns; this in turn led to its complete ban in most of the world. However, it has now been licensed for selected indications including graft-versushost-disease (GVHD) after bone marrow transplantation, wasting associated with tube...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید